Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort - Suárez-García I; Alejos B; Moreno C; de Miguel R; Aldámiz-Echevarría T; García-Fraile LJ; Tasias Pitarch M; Pérez Martinez D; Antela A; Moreno S; Jarrín I; Moreno S; et al. (Hiv Medicine, 2026)